Prostacyclin facilitates vascular smooth muscle cell phenotypic transformation via activating TP receptors when IP receptors are deficient

Apolipoprotein E favors the blunting by high-fat diet of IP receptor activation in the mouse aorta

(2018) Yanhua Cheng et al.   BRITISH JOURNAL OF PHARMACOLOGY

C1q/TNF-related protein 9 inhibits the cholesterol-induced Vascular smooth muscle cell phenotype switch and cell dysfunction by activating AMP-dependent kinase

(2017) Qi Liu et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Vascular structural and functional changes: their association with causality in hypertension: models, remodeling and relevance

(2016) Robert MKW Lee et al.   HYPERTENSION RESEARCH

An overview of potential molecular mechanisms involved in VSMC phenotypic modulation

(2015) Ming-Jie Zhang et al.   HISTOCHEMISTRY AND CELL BIOLOGY

Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis

(2015) Yu Sun et al.   JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION

Prostacyclin receptors: Transcriptional regulation and novel signalling mechanisms

(2015) Helen M. Reid et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

Mitogen-Activated Protein Kinase 14 Is a Novel Negative Regulatory Switch for the Vascular Smooth Muscle Cell Contractile Gene Program

(2012) Xiaochun Long et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Heterodimerization With the Prostacyclin Receptor Triggers Thromboxane Receptor Relocation to Lipid Rafts

(2012) Salam Ibrahim et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Prostacyclin Receptor Regulation --- from Transcription to Trafficking

(2012) C. Midgett et al.   CURRENT MOLECULAR MEDICINE

Atorvastatin Inhibits Myocardin Expression in Vascular Smooth Muscle Cells

(2012) Jingjing Li et al.   HYPERTENSION

Epigallocatechin Gallate Elicits Contractions of the Isolated Aorta of the Aged Spontaneously Hypertensive Rat

(2011) Zhuoming Li et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Endothelium-Dependent Contractions in Hypertension

(2011) Paul M. Vanhoutte   HYPERTENSION

Upregulation of Heme Oxygenase 1 by Hemin Impairs Endothelium-Dependent Contractions in the Aorta of the Spontaneously Hypertensive Rat

(2011) Zhuoming Li et al.   HYPERTENSION

Terutroban, a thromboxane/prostaglandin endoperoxide receptor antagonist, prevents hypertensive vascular hypertrophy and fibrosis

(2010) Paolo Gelosa et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Dominant Negative Actions of Human Prostacyclin Receptor Variant Through Dimerization: Implications for Cardiovascular Disease

(2010) Salam Ibrahim et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Endothelium-dependent contractions in SHR: a tale of prostanoid TP and IP receptors

(2009) Michel Félétou et al.   BRITISH JOURNAL OF PHARMACOLOGY

Rho Kinase Inhibitors Prevent Endothelium-Dependent Contractions in the Rat Aorta

(2009) C. K. Y. Chan et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Prostanoids and reactive oxygen species: Team players in endothelium-dependent contractions

(2009) Eva H.C. Tang et al.   PHARMACOLOGY & THERAPEUTICS

Aging and prostacyclin responses in aorta and platelets from WKY and SHR rats

(2008) Elodie Gomez et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Acceleration of Cardiovascular Disease by a Dysfunctional Prostacyclin Receptor Mutation

(2008) Eric Arehart et al.   CIRCULATION RESEARCH

Thromboxane A2: Physiology/pathophysiology, cellular signal transduction and pharmacology

(2008) Norimichi Nakahata   PHARMACOLOGY & THERAPEUTICS

Gene expression changes of prostanoid synthases in endothelial cells and prostanoid receptors in vascular smooth muscle cells caused by aging and hypertension

(2007) Eva H. C. Tang et al.   PHYSIOLOGICAL GENOMICS